CAPORASO, NICOLA
 Distribuzione geografica
Continente #
AS - Asia 10.124
NA - Nord America 8.656
EU - Europa 7.221
SA - Sud America 1.317
AF - Africa 242
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 11
Totale 27.583
Nazione #
US - Stati Uniti d'America 8.298
SG - Singapore 4.987
RU - Federazione Russa 3.051
CN - Cina 1.725
VN - Vietnam 1.687
IT - Italia 1.518
BR - Brasile 1.113
HK - Hong Kong 896
FR - Francia 414
SE - Svezia 395
FI - Finlandia 362
DE - Germania 349
UA - Ucraina 316
NL - Olanda 279
CA - Canada 218
GB - Regno Unito 184
JP - Giappone 160
IN - India 145
IE - Irlanda 132
BD - Bangladesh 88
AR - Argentina 81
MX - Messico 79
IQ - Iraq 72
PL - Polonia 57
ZA - Sudafrica 57
CI - Costa d'Avorio 52
TR - Turchia 44
PH - Filippine 39
TH - Thailandia 37
ID - Indonesia 35
AT - Austria 34
ES - Italia 31
CO - Colombia 26
MA - Marocco 26
TW - Taiwan 24
VE - Venezuela 24
EC - Ecuador 23
LT - Lituania 23
PK - Pakistan 20
UZ - Uzbekistan 18
KR - Corea 17
PY - Paraguay 17
CL - Cile 16
KE - Kenya 16
EG - Egitto 13
AZ - Azerbaigian 12
JO - Giordania 12
AE - Emirati Arabi Uniti 11
DZ - Algeria 11
AU - Australia 10
BE - Belgio 10
NP - Nepal 10
DO - Repubblica Dominicana 9
IR - Iran 9
JM - Giamaica 9
KG - Kirghizistan 9
NG - Nigeria 9
PE - Perù 8
PS - Palestinian Territory 8
SA - Arabia Saudita 8
TN - Tunisia 8
CH - Svizzera 7
ET - Etiopia 7
HN - Honduras 7
CR - Costa Rica 6
LV - Lettonia 6
RS - Serbia 6
IL - Israele 5
KZ - Kazakistan 5
LB - Libano 5
MY - Malesia 5
PA - Panama 5
RO - Romania 5
SN - Senegal 5
SY - Repubblica araba siriana 5
XK - ???statistics.table.value.countryCode.XK??? 5
AM - Armenia 4
AO - Angola 4
BO - Bolivia 4
CZ - Repubblica Ceca 4
EU - Europa 4
GR - Grecia 4
HU - Ungheria 4
PR - Porto Rico 4
PT - Portogallo 4
UY - Uruguay 4
AL - Albania 3
BA - Bosnia-Erzegovina 3
BG - Bulgaria 3
BS - Bahamas 3
BW - Botswana 3
BY - Bielorussia 3
BZ - Belize 3
GA - Gabon 3
GT - Guatemala 3
MD - Moldavia 3
MM - Myanmar 3
SO - Somalia 3
BH - Bahrain 2
BN - Brunei Darussalam 2
Totale 27.515
Città #
Singapore 2.145
San Jose 1.161
Hong Kong 872
Chandler 789
Moscow 747
Ashburn 512
Ho Chi Minh City 470
Beijing 436
Hanoi 366
Jacksonville 347
Santa Clara 335
Princeton 327
The Dalles 322
Millbury 320
Lauterbourg 301
Boston 284
Los Angeles 241
Nanjing 241
Amsterdam 202
Buffalo 155
New York 140
Tokyo 134
Ottawa 113
Napoli 104
Naples 98
Nanchang 95
São Paulo 93
Wilmington 92
Dallas 90
Da Nang 79
Des Moines 77
Milan 75
Redondo Beach 72
Haiphong 69
Munich 67
Boardman 64
Dong Ket 64
Rome 63
Frankfurt am Main 59
Hefei 57
Kronberg 52
Hebei 50
Seattle 50
Shenyang 47
Mexico City 45
Orem 45
Chicago 44
Warsaw 44
Council Bluffs 42
Rio de Janeiro 42
Bologna 39
Tianjin 38
Houston 37
Norwalk 34
Kunming 33
London 33
Falls Church 32
Toronto 32
Jiaxing 31
Montreal 31
Brooklyn 30
Changsha 29
Atlanta 28
Baghdad 28
Denver 28
Helsinki 28
Nuremberg 27
San Francisco 27
Stockholm 26
Poplar 25
Dublin 24
Johannesburg 23
Lawrence 23
Turku 23
Chennai 22
Phoenix 22
Hải Dương 21
Belo Horizonte 20
Biên Hòa 20
Shanghai 20
Brescia 19
Quận Ba 18
Salvador 18
Guangzhou 17
Tashkent 16
Thái Nguyên 16
Washington 16
Curitiba 14
Hangzhou 14
Mumbai 14
Orange 14
Porto Alegre 14
Vienna 14
Ankara 13
Brasília 13
Falkenstein 13
Manchester 13
Nairobi 13
New Delhi 13
Ann Arbor 12
Totale 13.867
Nome #
Terapia dell'ECA HBV-correlata 1.000
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 190
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 170
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial 168
Cross-sectional evaluation of transmural healing in patients with Crohn's disease on maintenance treatment with anti-TNF alpha agents 163
Bowel Damage in Crohn's Disease: Direct Comparison of Ultrasonography-based and Magnetic Resonance-based Lemann Index 160
Augmented Endoscopy for Surveillance of Colonic Inflammatory Bowel Disease: Systematic Review with Network Meta-Analysis 157
Eradication of HCV in Renal Transplant Recipients and Its Effects on Quality of Life 155
Coffee reduces liver damage in a rat model of steatohepatitis: the underlying mechanisms and the role of polyphenols and melanoidins 150
Validity and reliability of the Italian version of the Chronic Liver Disease Questionnaire (CLDQ-I) for the assessment of health-related quality of life. 149
A Simple Noninvasive Score Based on Routine Parameters can Predict Liver Cirrhosis in Patients With Chronic Hepatitis C 149
Beyond Irritable Bowel Syndrome: The Efficacy of the Low Fodmap Diet for Improving Symptoms in Inflammatory Bowel Diseases and Celiac Disease 149
Viral Outcome in Patients with Occult HBV Infection or HCV-Ab Positivity Treated for Lymphoma 148
Diagnostic Accuracy of Ultrasonography in the Detection of Postsurgical Recurrence in Crohn's Disease: A Systematic Review with Meta-analysis 147
Coffee prevents fatty liver disease induced by a high-fat diet by modulating pathways of the gut-liver axis 145
Efficacy of a "contact center-based communication" in optimizing the care of inflammatory bowel diseases 142
A new prognostic system for hepatocellular carcinoma: A retrospective study of 435 patients 140
Gluten-free diet does not influence the occurrence and the Th1/Th17-Th2 nature of immune-mediated diseases in patients with coeliac disease. 139
The burden of anaemia in patients with inflammatory bowel diseases 139
Alfa-glutathione transferases in HCV-related chronic hepatitis: a new predictive index of response to inteferon therapy? 137
Decaffeinated coffee consumption induces expression of tight junction proteins in high fat diet fed rats 135
Laser ablation is superior to TACE in large-sized hepatocellular carcinoma: A pilot case-control study 134
Direct-acting antivirals and hepatocellular carcinoma in chronic hepatitis C: A few lights and many shadows 134
Evidence for multipotent endodermal stem/progenitor cell populations in human gallbladder 134
On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites 134
A multi-stage genome-wide association study ofbladder cancer identifies multiple susceptibility loci 132
Beneficial effects of gluten free diet in potential coeliac disease in adult population 132
Prevalence and risk factors of HCV infection in a metropolitan area in southern Italy: Tail of a cohort infected in past decades 131
Berberis aristata, elaeis guineensis and coffea canephora extracts modulate the insulin receptor expression and improve hepatic steatosis in NAFLD patients: A pilot clinical trial 130
Metabolic syndrome in patients with coeliac disease on a gluten-free diet 129
Erratum to: Proton pump inhibitors as risk factor for metabolic syndrome and hepatic steatosis in coeliac disease patients on gluten-free diet 129
One-year clinical outcomes with biologics in Crohn's disease: transmural healing compared with mucosal or no healing. 128
Coffee and Intestinal Permeability in a Mice Model of Non-Alcoholic Fatty Liver Disease 128
Dietary supplementation of vitamin D prevents the development of western diet-induced metabolic, hepatic and cardiovascular abnormalities in rats 128
An emerging issue in differential diagnosis of diarrhea: sprue-like enteropathy associated with olmesartan 127
Combined endoscopic/sonographic-based risk matrix model for predicting one-year risk of surgery: A prospective observational study of a tertiary centre severe/refractory crohn's disease cohort 127
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 126
Decaffeinated coffee reduces gut leakiness in rats fed with high-fat diet. The role of Occludin and Zonulin-1 126
Circulating SCCA–IgM complex is a useful biomarker to predict the outcome of therapy in hepatocellular carcinoma patients 126
Metabolic disorders across hepatocellular carcinoma in Italy 126
Risk stratification of HCC occurrence after HCV eradication: a complicate plot of risk factors related and unrelated to the previous viral disease 124
The combination of berberine, tocotrienols and coffee extracts improves metabolic profile and liver steatosis by the modulation of gut microbiota and hepatic mir‐122 and mir‐34a expression in mice 124
Decaffeinated Coffee Reduces Body Weight Gain in Rats Fed With a Hfd by Modulating Intestinal Gpr41 and CCK Expression 123
Profiles of cancer stem cell subpopulations in cholangiocarcinomas 123
Prevalence of and risk factors for HBV infection in a metropolitan Southern Italian area: Evidence for the effectiveness of universal Hepatitis B vaccination 123
Psoriasis, Psoriatic Arthritis, or Psoriatic Disease? 122
"Il punto su:". L'ipertransaminasemia di ndd 122
Lack of evidence that adherence to standard of care therapy improves survival in subjects with hepatocellular carcinoma in clinical practice 122
Coffee and liver health 121
FRAX Score Can Be Used to Avoid Superfluous DXA Scans in Detecting Osteoporosis in Celiac Disease: Accuracy of the FRAX Score in Celiac Patients 121
Reactivation of hepatitis B or C in patients with IBD receiving immunosuppressive drugs. A multicentre study 120
Treatment of Hepatitis C virus infection in Italy: A consensus report from an expert panel 120
Proton pump inhibitors as risk factor for metabolic syndrome and hepatic steatosis in coeliac disease patients on gluten-free diet 120
Vitamin D levels and chronic hepatitis C 119
Coeliac disease in the elderly in a tertiary centre 119
BIOCHEMICAL MARKERS OF OXIDATIVE STRESS IN PERIPHERAL LYMPHOCYTES OF PATIENTS WITH HCV-RELATED LIVER DESEASES. 118
Apple polyphenols extract (APE) improves colon damage in a rat model of colitis 118
Decaffeinated Coffee Reduces Intestinal Leakiness in Rats Fed With a Hfd by Modulating Occludin and Zonulin-1 Expression 118
Timing strategies of direct-acting antivirals and biologics administration in HCV-infected subjects with inflammatory bowel diseases 118
Osteoporosis across chronic liver disease 117
Sustained virological response by direct antiviral agents in HCV leads to an early and significant improvement of liver fibrosis 117
Garlic extract prevents CCl(4)-induced liver fibrosis in rats: The role of tissue transglutaminase. 114
Vitamin D-PTH axis in HCV infection 114
Chronic hepatitis C: Interferon retreatment of relapsers. A Meta-analysis of individual patient data. 113
Serum insulin-like growth factor I evaluation as a useful tool for predicting the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis: a prospective study. 113
Skeletal muscle myopenia in mice model of bile duct ligation and carbon tetrachloride-induced liver cirrhosis 113
Spread of hepatitis C virus infection within families 112
Therapy expectations and physical comorbidity affect quality of life in chronic hepatitis C virus infection. 112
Impact of Diabetes on Outcomes of Sorafenib Therapy for Hepatocellular Carcinoma 112
Effect of immunosuppressive therapy on patients with inflammatory bowel diseases and hepatitis B or C virus infection. 111
AISF position paper on liver disease and pregnancy 111
Quality of life assessment in chronic liver disease. 110
Bowel sonography in predicting post-operative course of Crohn’s disease. 110
Parietal Healing in Patients With Crohn's Disease on Maintenance Treatment With Biologics 110
ONLINE ANALYSIS OF BREATH BY PROTON TRANSFER REACTION TIME OF FLIGHT MASS SPECTROMETRY IN CIRRHOTIC PATIENTS 110
Bioavailability of trans-resveratrol from red wine in humans. 108
The role of TMPRSS6 and HFE variants in iron deficiency anemia in celiac disease 107
Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) mimicking refractory celiac disease 106
Hepatitis-C virus infection in Italy: a multicentric sero-epidemiological study. (A report from the HCV study group of the Italian Association for the Study of the Liver) 105
Il ruolo dell'ecografia intestinale nel predire il decorso clinico post-operatorio della malattia di Crohn 105
Prevalence of HBcAg and delta-Ag in liver tissue of patients with HBsAg positive chronic hepatitis 105
Incidence of HCC recurrence after DAA treatment for HCV in a multicentre Italian cohort study 104
Performance of the model for end-stage liver disease score for mortality prediction and the potential role of etiology 102
HCV infection and hepatocellular carcinoma in cirrhotics: What is the linkage? 102
Tamoxifen in treatment of hepatocellular carcinoma: a randomised controlled trial. 102
parathyroid hormone-vitamin d axis in patients with chronic hepatitis c 102
Noninvasive diagnosis of small bowel Crohn's disease: direct comparison of bowel sonography and magnetic resonance enterography. 101
Incidence of site effects during therapy with different types of alpha interferon: a randomized controlled trial compared recombinant alpha 2-b versus leukocyte interferon in the therapy of naives patients with chronic hepatitis C 100
Foods and liver health 100
Interactions between metabolic disorders (diabetes, gallstones, and dyslipidaemia) and the progression of chronic hepatitis C virus infection to cirrhosis and hepatocellular carcinoma. A cross-sectional multicentre survey. 100
Systematic review: interferon-free regimens for patients with HCV-related Child C cirrhosis 100
Optimization of direct anti-viral agent treatment schedule: Focus on HCV genotype 3 99
Interferon-related thyroid autoimmunity and long-term clinical outcome of chronic hepatitis C. 97
Characteristic of liver cirrhosis in Italy: results from a multicenter national study 96
Hepatitis B and C virus reactivation in immunosuppressed patients with inflammatory bowel disease. 96
Predictive value of "Marsh 1" type histology in subjects with suspected cealic disease. 96
PNPLA3 rs738409 polymorphism predicts development and severity of hepatic steatosis but not metabolic syndrome in celiac disease 96
Liver resection is always a good choice for hepatocellular carcinoma (HCC) patients regardless of Barcelona Clinic Liver Cancer (BCLC) stage: the therapeutic hierarchy 95
The Role Of Gluten Intake At The Time Of Hepatitis B Vaccination In The Immune Response Of Celiac Patients. 94
Clinical significance of immunoglobulin M antibody to hepatitis C virus core. 93
Totale 13.098
Categoria #
all - tutte 89.804
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 89.804


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202180 0 0 0 0 0 0 0 0 0 0 0 80
2021/20221.527 50 7 12 12 5 30 27 56 137 61 271 859
2022/20231.979 384 115 46 184 250 214 10 201 273 202 77 23
2023/20241.206 46 176 94 62 40 98 56 145 19 33 287 150
2024/20257.472 463 628 42 73 176 224 728 411 979 723 2.339 686
2025/202612.390 1.577 816 1.252 1.028 2.253 560 1.237 891 1.625 809 285 57
Totale 27.881